Sinovac Biotech Ltd. (NASDAQ:SVA)

CAPS Rating: 2 out of 5

A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

Results 1 - 20 of 66 : 1 2 3 4 Next »

Recs

0
Member Avatar kylehusky (< 20) Submitted: 7/1/2011 3:38:20 AM : Outperform Start Price: $3.20 SVA Score: +1.50

pharm. stock is always risky, but when disease pops out this is the best pharm. stock you can bet in China.

Recs

0
Member Avatar ChinaBottom (< 20) Submitted: 6/24/2011 12:10:00 AM : Outperform Start Price: $3.15 SVA Score: -0.59

Tracking portfolio for China based companies that gained listings on US exchanges (Nasdaq, NYSE, or Amex) after conducting reverse mergers. Stocks that have been delisted have been omitted. Start date: Jun 24, average P/E of these companies: 3.

Recs

0
Member Avatar rockportfred (79.79) Submitted: 5/23/2011 11:26:42 AM : Outperform Start Price: $4.01 SVA Score: -29.71

chinese company liked by the chinese government and selling to the government

Recs

0
Member Avatar ChinaRTO (99.89) Submitted: 4/14/2011 3:38:32 AM : Underperform Start Price: $3.97 SVA Score: +29.88

This is a tracking portfolio of all CAPS-ratable tickers in the Chinese RTO/SPAC space (i.e., companies that listed without filing an IPO).

Sinovac Biotech Ltd. went public via a reverse merger in 2003. The company is based in China.

Recs

0
Member Avatar targetphil3 (< 20) Submitted: 11/12/2010 6:08:14 PM : Outperform Start Price: $4.15 SVA Score: -48.13

could be a multibagger, high insider ownership, 46% eps 3yrs, 43% rev. growth 3yrs, plus upcoming trials

Recs

0
Member Avatar gnikool10 (< 20) Submitted: 11/12/2010 12:46:46 PM : Underperform Start Price: $4.30 SVA Score: +53.32

They have reduced the guidance. $3 might be a good buy.

Recs

0
Member Avatar spud2288 (22.88) Submitted: 10/25/2010 10:34:29 AM : Outperform Start Price: $3.66 SVA Score: -34.28

Vaccine production

Recs

1
Member Avatar kayceygirl (78.63) Submitted: 8/14/2010 1:39:18 AM : Outperform Start Price: $4.52 SVA Score: -77.95

This is one of my STARZ.
Here is the thought process on this STAR:
a) Divided rate over Zero
b) 3 Year Beta between -5 & +3
c) 15% + Insider ownership
d) No greater than -50% Growth rate for the last 3 years (tough last couple of years so good that insiders are still owning the stocks)
e) Current CAPS rating between 3 Stars & 5 Stars
Open to all Industries and Sectors screened this down to just 250 stocks. I like round numbers. 12 of them I already own through other screening tools. I tend to be somewhat conservative but looking for 3 things at this point in my investing:
1. Stability & Strength
2. Yield and Modest Growth
3. Strong Position within a sector regardless of whether the
entire sector is strong or not. Each sector has to perform to some degree for the whole world economy to function. I am looking for 5 or more years down the road, ROI, and Growth. Not looking for rockets, just stars. This is a Star!!

Recs

0
Member Avatar TheVVRT (48.11) Submitted: 1/26/2010 11:32:12 PM : Outperform Start Price: $6.30 SVA Score: -105.91

Boom Boom 5% boom wait 2 weeks and youll be out in a zoom zoom

Recs

0
Member Avatar blrrx (< 20) Submitted: 12/15/2009 8:00:29 PM : Outperform Start Price: $6.50 SVA Score: -103.98

Flu season here and abroad especially in countries like China etc and Europe

Recs

0
Member Avatar kleio (35.96) Submitted: 11/30/2009 6:29:18 PM : Outperform Start Price: $7.55 SVA Score: -115.91

This could be the age of epidemics. Vaccines are a hit or miss but if you hit, it's going to be a homer.

Recs

0
Member Avatar altheartist (< 20) Submitted: 11/25/2009 11:49:32 AM : Outperform Start Price: $7.45 SVA Score: -114.23

People in China are getting sick .

Recs

0
Member Avatar plvo38 (< 20) Submitted: 10/27/2009 11:19:10 AM : Outperform Start Price: $8.38 SVA Score: -129.13

swine blu will spread, more and more cases reported, sva getting more orders weekly

Recs

1
Member Avatar sedaohr2 (< 20) Submitted: 10/26/2009 11:36:39 AM : Outperform Start Price: $7.85 SVA Score: -123.92

This a no-brainer with all the announcements about orders and shippments. Very good growth, and short term money that can be turned back into the company.

Recs

1
Member Avatar BEEST22 (< 20) Submitted: 10/20/2009 10:27:15 AM : Outperform Start Price: $8.11 SVA Score: -122.82

Swineflu is breaking out at the moment. A lot of vaccins will be needed !

Recs

1
Member Avatar cjang123 (< 20) Submitted: 10/18/2009 1:17:37 PM : Outperform Start Price: $8.42 SVA Score: -125.70

"China's 1.3 billion people + first H1N1 vaccine" give this one a winner for sure!

Recs

0
Member Avatar Kid6521 (< 20) Submitted: 10/14/2009 7:10:34 AM : Outperform Start Price: $8.39 SVA Score: -126.08

Exposure to Japan and China Flu markets is a great engine for growth

Recs

0
Member Avatar skino338 (< 20) Submitted: 10/14/2009 6:33:48 AM : Outperform Start Price: $8.39 SVA Score: -126.08

1.third orders will be coming end of this month

2.Q3 ER Nov 16th

Recs

4
Member Avatar malcolmcochran (68.37) Submitted: 10/10/2009 11:41:34 AM : Outperform Start Price: $7.84 SVA Score: -123.62

1) Serious company, focused on single idea (vaccines) with many apps.
2) Vaccines are regaining importance
3) World's second biggest economy as its home market
4) Using best practice
5) Doggedly using US accounting rules
6) Home currency (yuan) can only rise against other denominations
7) Still has good metrics, and its H1N1 profit isn't yet in.

Recs

0
Member Avatar grants1 (< 20) Submitted: 9/28/2009 7:46:29 PM : Outperform Start Price: $8.27 SVA Score: -129.06

As different viruses become more prevelent and difficult to treat these vaccine makers will be more and more valuable. They are small and capable of adjusting to the markets needs faster than the large companies. This will continue to make them more valuable and attract big names to possibly buy them.

Results 1 - 20 of 66 : 1 2 3 4 Next »

Featured Broker Partners


Advertisement